Central European Institute of Technology

Commsignia Announces Funding of USD 15M in Series B Round

Retrieved on: 
Tuesday, September 5, 2023
Karma, Communication, Partnership, Civil service commission, LG Electronics, Accident, Central European Institute of Technology, Qualcomm Ventures, Original equipment manufacturer, Policy, Ford, Electronics, General partnership, Research, Element, Inventure Academy, Trust, Volkswagen, Audi, Dampfschiffahrts-Gesellschaft für den Nieder- und Mittelrhein, Credo, City, Growth, Ecosystem, Transport, Samsung Catalyst Fund, Pedestrian, European Commission, Safety, Injury, Asset management, Road, Renewable energy, Video game, V2X

SANTA CLARA, Calif., Sept. 5, 2023 /PRNewswire-PRWeb/ -- Commsignia, Inc., the largest company focusing on Vehicle-to-Everything (V2X) solutions, announced the closing of an USD 15 million Series B fundraising round led by PortfoLion Capital Partners, Inventure, Day One Capital and Inference Partners, together with Partech, Credo Ventures, and Karma Ventures. The fundraising round sees LG Electronics joining as a strong strategic partner along with existing strategic investors Samsung Catalyst Fund and Qualcomm Ventures. With this investment, the company aims to strengthen its leadership and grow faster in new markets and geographies as the digital transformation of the transport and automotive industry gains momentum.

Key Points: 
  • This new investment round brings Commsignia and its partners closer to significantly reducing the number of traffic fatalities and injuries.
  • The fundraising round sees LG Electronics joining as a strong strategic partner along with existing strategic investors Samsung Catalyst Fund and Qualcomm Ventures.
  • Their relentless pursuit of pioneering advancements in connected vehicle technology and the enormous market potential have made our decision to co-lead their Series B round very easy.
  • "Commsignia is an important player in the V2X ecosystem, and we are happy to invest in their journey towards further growth and success."

ADM Board of Directors Enhances R&D, Innovation Expertise with Nomination of Elanco Executive Ellen de Brabander

Retrieved on: 
Tuesday, March 14, 2023
Agriculture, Natural Resources, Consumer, Pets, Other Natural Resources, Multimedia, Research, Retirement, Royal Netherlands Chemical Society, NYSE, Massachusetts Institute of Technology, Partnership, Boehringer Ingelheim, DSM, Yves De Brabander, Merck & Co., Schering-Plough, Investment, Leiden University, Animal, Food safety, ADM, Growth, Innovation, Publication, Molecular biology, Doctor of Philosophy, PepsiCo, Central European Institute of Technology, European Institute, Public policy, Management, Elanco

ADM (NYSE: ADM), a global leader in human and animal nutrition, today announced that its Board of Directors has nominated Elanco executive vice president for Innovation and Regulatory Affairs, Dr. Ellen de Brabander, to stand for election to the Board at the company’s upcoming Annual Stockholders’ Meeting on May 4, 2023.

Key Points: 
  • ADM (NYSE: ADM), a global leader in human and animal nutrition, today announced that its Board of Directors has nominated Elanco executive vice president for Innovation and Regulatory Affairs, Dr. Ellen de Brabander, to stand for election to the Board at the company’s upcoming Annual Stockholders’ Meeting on May 4, 2023.
  • De Brabander has also held executive leadership positions in Boehringer Ingelheim (then known as Merial), Merck Animal Health (previously Intervet), and DSM.
  • ADM also announced that Lead Director Donald Felsinger will retire from the Board, having reached the retirement age of 75.
  • “When Don Felsinger joined our Board of Directors in 2009, ADM was a very different company,” Luciano said.